跳转至内容
Merck
CN
  • Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.

Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (2014-06-17)
Gozde Unsoy, Rouhollah Khodadust, Serap Yalcin, Pelin Mutlu, Ufuk Gunduz
摘要

Targeted drug delivery is a promising alternative to overcome the limitations of classical chemotherapy. In an ideal targeted drug delivery system carrier nanoparticles would be directed to the tumor tissue and selectively release therapeutic molecules. As a novel approach, chitosan coated magnetic nanoparticles (CS MNPs) maintain a pH dependent drug delivery which provides targeting of drugs to the tumor site under a magnetic field. Among various materials, chitosan has a great importance as a pH sensitive, natural, biodegradable, biocompatible and bioadhesive polymer. The aim of this study was to obtain an effective targeted delivery system for Doxorubicin, using chitosan coated MNPs. Different sized CS MNPs were produced by in situ synthesis method. The anti-cancer agent Doxorubicin was loaded onto CS MNPs which were characterized previously. Doxorubicin loading was confirmed by FTIR. Drug loading and release characteristics, and stability of the nanoparticles were investigated. Our results showed that the CS MNPs have pH responsive release characteristics. The cellular internalization of Doxorubicin loaded CS MNPs were visualized by fluorescent microscopy. Doxorubicin loaded CS MNPs are efficiently taken up by MCF-7 (MCF-7/S) and Doxorubicin resistant MCF-7 (MCF-7/1 μM) breast cancer cells, which increases the efficacy of drug and also maintains overcoming the resistance of Doxorubicin in MCF-7/Dox cells. Consequently, CS MNPs synthesized at various sizes can be effectively used for the pH dependent release of Doxorubicin in cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
二甲基亚砜, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
二甲基亚砜, ACS reagent, ≥99.9%
Sigma-Aldrich
二甲基亚砜, Molecular Biology
Sigma-Aldrich
二甲基亚砜, suitable for HPLC, ≥99.7%
Sigma-Aldrich
氢氧化铵 溶液, ACS reagent, 28.0-30.0% NH3 basis
Sigma-Aldrich
二甲基亚砜, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
二甲基亚砜, ReagentPlus®, ≥99.5%
Sigma-Aldrich
二甲基亚砜, anhydrous, ≥99.9%
Sigma-Aldrich
二甲基亚砜, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
氢氧化铵 溶液, 28% NH3 in H2O, ≥99.99% trace metals basis
Sigma-Aldrich
二甲基亚砜, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
三聚磷酸钠, technical grade, 85%
Sigma-Aldrich
氢氧化铵 溶液, puriss., 30-33% NH3 in H2O
Sigma-Aldrich
二甲基亚砜, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
三磷酸五钠 五元, purum p.a., ≥98.0% (T)
Sigma-Aldrich
氢氧化铵 溶液, puriss. p.a., reag. ISO, reag. Ph. Eur., ~25% NH3 basis
Sigma-Aldrich
二甲基亚砜, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
二甲基亚砜, PCR Reagent
Sigma-Aldrich
氢氧化铵 溶液, BioUltra, ~1 M NH3 in H2O (T)
Sigma-Aldrich
氢氧化铵 溶液, puriss., meets analytical specification of Ph. Eur., 25-30% NH3 basis
Sigma-Aldrich
二甲基亚砜, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
氢氧化铵 溶液, puriss. p.a. plus, ≥25% NH3 in H2O
Supelco
二甲基亚砜, analytical standard
USP
二甲基亚砜, United States Pharmacopeia (USP) Reference Standard
Supelco
二甲基亚砜, for inorganic trace analysis, ≥99.99995% (metals basis)
二甲基亚砜, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
二甲基亚砜, Vetec, reagent grade, 99%
Sigma-Aldrich
二甲基亚砜, ≥99.6%, ReagentPlus®